Medicine
Stromectol 3 mg tablet
Stromectol 3 mg tablet is a prescription medicine containing Ivermectin for oral use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at temperatures below 30°C (86°F).
Key facts
- Active ingredient (INN)
- Ivermectin
- Brand
- Stromectol
- Strength
- 3 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 2 blister pack
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- Store at temperatures below 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D11AX22 Ivermectin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 November 1996
- Identifiers
- RxCUI 261314, 311207DailyMed set ID 681888c9-af79-4b7d-ae80-c3f4f6f1effdNDC 0006-0032Application NDA050742
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 carton / 10 tablet in 1 blister pack | 0006-0032-01 | Merck Sharp & Dohme | 20 September 2024 |
| 2 blister pack in 1 carton / 10 tablet in 1 blister pack | 0006-0032-20 | Merck Sharp & Dohme | 22 November 1996 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 November 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ivermectin 3 mg tablet.
Other strengths and forms of Ivermectin
Clinical summary
Ivermectin is an antiparasitic indicated for the treatment of infections, among other approved uses. It is available as tablets and cream for oral and topical use. MedsAcross supplies Ivermectin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IvermectinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- STROMECTOL prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
Need Stromectol 3 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.